Indoleamine 2,3-dioxygenase in tumor induced tolerance
- PMID: 20137504
Indoleamine 2,3-dioxygenase in tumor induced tolerance
Abstract
Objective: To review the recent studies about the role of indoleamine 2,3-dioxygenase (IDO) in tumor induced tolerance.
Data sources: Published articles (1978 - 2009) on IDO and tumor induced tolerance were selected from Medline.
Study selection: Articles selected were relevant to development of IDO in tumor induced tolerance. Of all originally identified articles, 50 specially addressed the stated purpose.
Results: Recent work has revealed IDO at high levels in tumors and in tumor-draining lymph nodes and a close relationship between IDO activity and the regulatory T cells.
Conclusion: Up-regulation of IDO is proven to be a mechanism of acquired tolerance in tumors, in which the closely coupled positive feedback system between IDO and regulatory T cells may be considered to play an important role.
Similar articles
-
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.Curr Opin Immunol. 2006 Apr;18(2):220-5. doi: 10.1016/j.coi.2006.01.002. Epub 2006 Feb 7. Curr Opin Immunol. 2006. PMID: 16460921 Review.
-
Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.J Am Coll Surg. 2008 May;206(5):849-54; discussion 854-6. doi: 10.1016/j.jamcollsurg.2007.12.014. Epub 2008 Mar 4. J Am Coll Surg. 2008. PMID: 18471709
-
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.J Clin Invest. 2007 May;117(5):1147-54. doi: 10.1172/JCI31178. J Clin Invest. 2007. PMID: 17476344 Free PMC article. Review.
-
Tumor immune escape mediated by indoleamine 2,3-dioxygenase.Immunol Lett. 2007 Aug 15;111(2):69-75. doi: 10.1016/j.imlet.2007.06.001. Epub 2007 Jul 2. Immunol Lett. 2007. PMID: 17644189 Review.
-
Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e243-50. doi: 10.1111/j.1440-1746.2007.05036.x. Epub 2007 Jul 23. J Gastroenterol Hepatol. 2008. PMID: 17645734
Cited by
-
Immune system: a double-edged sword in cancer.Inflamm Res. 2013 Sep;62(9):823-34. doi: 10.1007/s00011-013-0645-9. Epub 2013 Jul 19. Inflamm Res. 2013. PMID: 23868500 Review.
-
Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state.J Biol Chem. 2011 Mar 11;286(10):8030-8042. doi: 10.1074/jbc.M110.172114. Epub 2010 Dec 28. J Biol Chem. 2011. PMID: 21189261 Free PMC article.
-
Stromal cell-based immunotherapy in transplantation.Immunotherapy. 2011 Dec;3(12):1471-85. doi: 10.2217/imt.11.132. Immunotherapy. 2011. PMID: 22091683 Free PMC article. Review.
-
Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources.Front Pharmacol. 2022 Nov 4;13:1046818. doi: 10.3389/fphar.2022.1046818. eCollection 2022. Front Pharmacol. 2022. PMID: 36408235 Free PMC article. Review.
-
Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer.Front Endocrinol (Lausanne). 2023 Nov 22;14:1265525. doi: 10.3389/fendo.2023.1265525. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38075052 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials